Arginine, arginine analogs and nitric oxide production in chronic kidney disease. - Test2 - elhamkhani - TriplyDB

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

http://www.wikidata.org/entity/Q36577145

about

Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation Nitric oxide synthase derangements and hypertension in kidney disease Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables Erectile dysfunction in chronic kidney disease: From pathophysiology to management Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass.Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction.Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats.Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Left atrial volume index and aortic stiffness index in adult hemodialysed patients--link between compliance and pressure mediated by endothelium dysfunction; a cross-sectional study Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers.Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.Peripheral vascular dysfunction in chronic kidney disease Protein-energy wasting and mortality in chronic kidney disease.Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model.Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management Amelioration of progressive renal injury by genetic manipulation of Klotho gene.IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis Nitric oxide status in patients with chronic kidney disease.Sexual dimorphism in development of kidney damage in aging Fischer-344 rats Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation.Renal Nitric Oxide Deficiency and Chronic Kidney Disease in Young Sheep Born with a Solitary Functioning Kidney.The Association of Dietary l-Arginine Intake and Serum Nitric Oxide Metabolites in Adults: A Population-Based Study.Small Molecule Inhibitors of Protein Arginine Methyltransferases.Sexual dimorphism of the aging kidney: role of nitric oxide deficiency.The promise of cell-based therapies for diabetic complications: challenges and solutions The antihypertensive effect of arginine.Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study.Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine Cellular ADMA: regulation and action.SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography Role of asymmetrical dimethylarginine in the progression of renal disease.Asymmetric dimethylarginine, endothelial dysfunction and renal disease Loss of a kidney during fetal life: long-term consequences and lessons learned.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.

P2860

Q23912498-93466FA4-6B32-4BDB-9814-CFB4DE62377A Q26849234-1156ADFB-A12D-4C6D-B88D-B7B8782BDDD9 Q26865426-02382D9E-3889-4227-8E13-D5A3383574D8 Q28084286-EC61CFB5-E227-4860-8623-C7F2D175BA61 Q28565167-0DF9A009-8119-4F0F-8243-500B666F195F Q28580038-447E0268-C24B-476C-9456-31AA7E6376BA Q30418412-3944807E-C694-4326-9D29-36DA75C36F33 Q33594240-BC594026-7E17-412E-827A-ED8FC682D58E Q33651819-1429BDF9-73BC-4F14-BB63-C03F14D79C1C Q34008329-68D946B6-3824-4F0B-A217-46F0825FD63B Q34466020-4CE0923D-E994-4AA8-B657-0E586FEEE1E5 Q34586038-2B846956-D507-4E40-94E6-EAE87229ACB8 Q34724943-D7193FA4-1719-4796-B304-7B09D631FE14 Q34747124-57829520-0D19-4A4F-AFDB-219302E1825B Q35008316-D9903A78-E2F1-43A7-9D25-0FBC65502C74 Q35012914-5CC6C9AF-CF10-4878-A0A4-AF5D6CE02344 Q35024794-9F2BAD17-3D29-4FDB-8ABC-007DCFA2106D Q35167343-59D77EEC-CDC3-4DB4-B371-A82B39BEBCE9 Q35606449-87C9853E-EB5D-4B23-91EF-40A4EB3251E0 Q35844644-F829A860-EA55-48F2-950B-5E4581114A48 Q35946057-59787807-506E-4366-8CCC-0DC0D1D0EB87 Q36074375-82CC9C5B-346A-4CEE-B354-96E6CD6FB05D Q36106127-FEDC8182-576A-4C82-B868-257F3115EE60 Q36289988-6448BD97-9676-4311-89DF-B4B3D53F7958 Q36468986-92082C38-EEA4-42EB-84C5-879E40F0A258 Q36937415-84062CD1-6B9D-4E2B-AA0D-6BBB2F33B362 Q36941892-6CBDDC8B-A42C-47AD-9E9E-B5A31DEB47AD Q37056442-4794E371-C490-4941-9B85-E75FFAC1A035 Q37192036-54F1EA8D-5C55-4F63-9BCF-10DF6CD48F39 Q37276042-48559655-A19F-4448-AC87-C2A3EDA2350C Q37309054-1094755B-DE3E-43B5-8CB1-B1E530F936B3 Q37374598-34623E9A-6753-48EE-B92C-ABB32E680C3E Q37397252-4F17B23F-1E24-4C55-B9E0-F817197FFDED Q37399711-38356130-740E-40D8-BEE1-AB717E56AAA8 Q37477751-8579D98D-CFAA-4681-9E2B-070857CB889D Q37646687-72E455C2-1311-4A08-822E-773AE1C31D0A Q38046935-DDF55A48-7567-48C3-9C7E-D86C0682F943 Q38056493-65023D93-39C7-4B10-B3BB-E6E416B44B94 Q38185596-A1A58FDC-E7FB-4BF9-B4C2-EF1A99E570E1 Q38194032-AD5734FA-B482-406A-9F1E-52A819C82751

P2860

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

http://www.wikidata.org/entity/Q36577145

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@ast

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@en

type

label

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@ast

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@en

prefLabel

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@ast

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@en

P1433

Q36577145-5B930AF9-2CAC-4028-9053-122D42DAB02B

P1476

Q36577145-EDDC4A65-E2E5-44DF-8B3A-DDFC0DE5AE48

P2093

Q36577145-BDB788CB-106C-4564-A21E-D2D99741F584

P2860

Q36577145-01A49000-756E-4E0D-BAC4-457144C3D88B

Q36577145-024357A0-E134-4E36-88A9-8FB834698BBC

Q36577145-02A6B40E-BCD8-4AE1-8509-39AAEA446F30

Q36577145-05C394EF-7D4B-4D83-AA53-A5FFC96C1F36

Q36577145-06934DB3-1D48-4C19-946C-D1573535F5B9

Q36577145-0A7ED36E-C6E0-4BC9-A6D1-50E640854DB2

Q36577145-0B0D8812-C3EA-4C55-BCB7-DADDA1331940

Q36577145-0ED129BF-08DA-47AD-9CA8-D320025E25F0

Q36577145-0FB86492-AEA0-4579-B76F-14F51DBD81AC

Q36577145-0FC998F2-8BF7-4193-92F1-A580917B1FED

P304

Q36577145-4C24D931-D116-4F96-AAE3-A542F7979B05

P31

Q36577145-03382FFE-D396-4C8A-9BB0-1CC6442D4C48

P356

Q36577145-28F01E48-EE6F-4DB7-BD42-D7C813051967

P433

Q36577145-7CC8D7F7-44F0-47CD-B573-84934896A803

P478

Q36577145-EAA8F825-B563-49F6-BB95-A950D41FAE95

P577

Q36577145-79BDC98C-798F-4063-982B-DED2AE077CBF

P5875

Q36577145-A53B7E69-EE6A-4E73-92EC-C1E6A4AABD82

P698

Q36577145-CCC0E67C-8B02-4C0F-AE90-5E569F430E1A

P932

Q36577145-8D1CAAA3-69E8-4255-A744-F6A7C960BAA9

P356

P1433

Nature Clinical Practice Nephrology

P1476

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

@en

P2093

Chris Baylis

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

Arginine metabolism: nitric oxide and beyond

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats

Vascular endothelial cells synthesize nitric oxide from L-arginine

Total nitric oxide production is low in patients with chronic renal disease

Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease

Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells

P304

209-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPNEPH0143

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6856806

http://www.w3.org/2001/XMLSchema#string

P698

16932427

http://www.w3.org/2001/XMLSchema#string

P932

2756810

http://www.w3.org/2001/XMLSchema#string